- Home
- About
- Section Advisors
- Meet Our Field Medical Affairs Team
- Speakers Bureau
- Supporting Organizations
- Contact Us
- Resource Library
- Mental Health Disorders
- Agitation
- Anxiety Disorders
- Bipolar Disorder
- Cognition
- Depression
- Eating Disorders
- Personality Disorders
- PTSD/Trauma
- Schizophrenia
- Substance Use Disorders
- Women’s Health
- Topics of Interest
- Care Coordination
- Digital Health
- Diversity, Equity, & Inclusion
- Early Episode Psychosis
- Health Care Policy & Legislation
- Neuroscience
- Payer & Financing Models
- Quality Standards & Performance Measures
- Stigma
- Suicide Awareness
- Wellness
- Collections
- Featured
- Monthly Spotlight
- Psychopharmacology
- Learning Tracks
- Community Insights
- Community Podcast
- Disease Management & Support Tools
- Frameworks In Health & Quality Resources
- Mental Health System Guidebooks
- Patient & Caregiver Resource Center
- PsychU Roleplay
- Psychiatric Scales
- PsychUSim
- Events
Virtual Event – Trace Amine-Associated Receptor 1 (TAAR1): A Potential New Target For The Treatment of Schizophrenia
Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:
About This Event
Virtual Event – Trace Amine-Associated Receptor 1 (TAAR1): A Potential New Target For The Treatment of Schizophrenia
This is a Virtual Event for PsychU members in Maryland, Washington, DC, and Virginia.
Trace amines and trace amine-associated receptors (TAAR) are found throughout the brain and peripheral tissues and have modulating effects on neurotransmitters including dopamine, glutamate, and serotonin.1,2 The speaker(s) will discuss what are some of the potential effects of TAAR1 on neurotransmitter signaling related to schizophrenia and some of the preclinical data, as well as share the potential role of TAAR1 beyond schizophrenia.
Objectives:
- Summarize the Unmet Needs of Schizophrenia as it Relates to Neural Circuitry
- Introduction to Trace Amines (TA) and Trace Amine-Associated Receptors (TAARs) and Their Potential Relationship to Schizophrenia
- Discuss Potential Modulating Effects of TAAR1 on Neurotransmitter Signaling Associated with Schizophrenia Pathophysiology
Featuring
Dennis Sholler, PhD (OPDC)
Clinical & Scientific Liaison
Speaker Dennis Sholler, PhD is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)
Related Events
-
Virtual Event – Trace Amine-Associated Receptor 1 (TAAR1): A Potential New Target For The Treatment Of Schizophrenia
April 27 12:00 pm to 1:00 pm
Registration
Log in to register
Related Resources
-
PsychU Brochure 2023
Downloadable Resource January 31, 2023Download Brochure
-
Pharmacokinetics, Plasma Concentrations (Their) & Clinical Relevance
On-Demand Webinar January 26, 2023Pharmacokinetics refers to the study of how drugs are processed by the body. These processes play an important role in mental health treatments, and can vary due to several factors,…
-
The Holidays – A Time For Silver, Gold, and… The Blues?
Podcast January 17, 2023Listen to Amica Simmons-Yon, PharmD, PhD and Alyssa Peckham, PharmD, BCPP as they spill the tea on The Holiday Blues with special guest, Bennett Doughty, PharmD, BCPS, BCPP. During this…
Stay Connected: